AU1604401A - 18 human secreted proteins - Google Patents

18 human secreted proteins

Info

Publication number
AU1604401A
AU1604401A AU16044/01A AU1604401A AU1604401A AU 1604401 A AU1604401 A AU 1604401A AU 16044/01 A AU16044/01 A AU 16044/01A AU 1604401 A AU1604401 A AU 1604401A AU 1604401 A AU1604401 A AU 1604401A
Authority
AU
Australia
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16044/01A
Inventor
Kevin P. Baker
George A. Komatsoulis
Steven M. Ruben
Paul E. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU1604401A publication Critical patent/AU1604401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU16044/01A 1999-11-19 2000-11-15 18 human secreted proteins Abandoned AU1604401A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16641599P 1999-11-19 1999-11-19
US60166415 1999-11-19
US21513600P 2000-06-30 2000-06-30
US60215136 2000-06-30
PCT/US2000/031162 WO2001036432A2 (en) 1999-11-19 2000-11-15 18 human secreted proteins

Publications (1)

Publication Number Publication Date
AU1604401A true AU1604401A (en) 2001-05-30

Family

ID=26862246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16044/01A Abandoned AU1604401A (en) 1999-11-19 2000-11-15 18 human secreted proteins

Country Status (5)

Country Link
EP (1) EP1234030A4 (en)
JP (1) JP2003514541A (en)
AU (1) AU1604401A (en)
CA (1) CA2388777A1 (en)
WO (1) WO2001036432A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419663B2 (en) 1998-03-20 2008-09-02 Genentech, Inc. Treatment of complement-associated disorders
US8088386B2 (en) * 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
US7192589B2 (en) * 1998-09-16 2007-03-20 Genentech, Inc. Treatment of inflammatory disorders with STIgMA immunoadhesins
ES2252261T3 (en) 2000-06-28 2006-05-16 Glycofi, Inc. METHODS TO PRODUCE MODIFIED GLICOPROTEINS.
US7625756B2 (en) 2000-06-28 2009-12-01 GycoFi, Inc. Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
US7598055B2 (en) 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7449308B2 (en) 2000-06-28 2008-11-11 Glycofi, Inc. Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
EP1445317A3 (en) * 2000-08-24 2004-12-15 Genentech Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004022594A2 (en) * 2002-09-06 2004-03-18 Cytos Biotechnology Ag Immune modulatory compounds and methods
US7332299B2 (en) * 2003-02-20 2008-02-19 Glycofi, Inc. Endomannosidases in the modification of glycoproteins in eukaryotes
JP4897690B2 (en) * 2004-10-12 2012-03-14 ジェネンテック， インコーポレイテッド CRIg polypeptide for prevention and treatment of complement related disorders
EP3299027A1 (en) 2005-11-04 2018-03-28 Genentech, Inc. Use of complement pathway inhibitors to treat ocular diseases
US7776573B2 (en) 2006-06-01 2010-08-17 Genentech, Inc. Crystal structure of CRIg and C3b:CRIg complex
CA2939806A1 (en) 2006-11-02 2008-05-08 Genentech, Inc. Humanized anti-factor d antibodies and uses thereof
AR066660A1 (en) 2007-05-23 2009-09-02 Genentech Inc PREVENTION AND TREATMENT OF EYE CONDITIONS ASSOCIATED WITH THEIR COMPLEMENT
CR20170001A (en) 2008-04-28 2017-08-10 Genentech Inc ANTI FACTOR D HUMANIZED ANTIBODIES
RU2553517C2 (en) 2008-05-06 2015-06-20 Дженентек, Инк. Affinity-matured crig versions
KR101137019B1 (en) * 2009-05-25 2012-05-24 한국생명공학연구원 A novel g protein coupled receptor and a use thereof
EP2927242A1 (en) 2010-04-09 2015-10-07 Amgen, Inc Btnl9 proteins, nucleic acids, and antibodies and uses thereof
JP6463359B2 (en) 2013-08-12 2019-01-30 ジェネンテック， インコーポレイテッド Compositions and methods for treating complement related conditions
WO2015168468A1 (en) 2014-05-01 2015-11-05 Genentech, Inc. Anti-factor d antibody variants and uses thereof
CN108472382A (en) 2015-10-30 2018-08-31 豪夫迈·罗氏有限公司 Anti- factor D antibody variants conjugate and application thereof
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates
WO2017150681A1 (en) * 2016-03-03 2017-09-08 東亞合成株式会社 Amyotrophic lateral sclerosis diagnostic method using signal peptide as index

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001550A1 (en) * 1997-07-03 1999-01-14 Dana-Farber Cancer Institute A method for detection of alterations in msh5
JPH11313673A (en) * 1998-04-30 1999-11-16 Hoechst Marion Roussel Kk Human bmp-2 promotor and screening of bone-related substance using the same
CA2384659A1 (en) * 1999-09-27 2001-04-05 Craig A. Rosen 37 human secreted proteins

Also Published As

Publication number Publication date
JP2003514541A (en) 2003-04-22
WO2001036432A3 (en) 2002-05-10
CA2388777A1 (en) 2001-05-25
WO2001036432A2 (en) 2001-05-25
EP1234030A2 (en) 2002-08-28
EP1234030A4 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
AU1473501A (en) 21 human secreted proteins
AU1438001A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU1334101A (en) 19 human secreted proteins
AU3769700A (en) 45 human secreted proteins
AU2757500A (en) 33 human secreted proteins
AU3517000A (en) 50 human secreted proteins
AU1918601A (en) 23 human secreted proteins
AU3628600A (en) 46 human secreted proteins
AU1916101A (en) 19 human secreted proteins
AU3765500A (en) 50 human secreted proteins
AU1342501A (en) 32 human secreted proteins
AU3208700A (en) 33 human secreted proteins
AU3396600A (en) 49 human secreted proteins
AU3249300A (en) 47 human secreted proteins
AU1449001A (en) 28 human secreted proteins
AU5306900A (en) 49 human secreted proteins
AU1472801A (en) 24 human secreted proteins
AU3871300A (en) 50 human secreted proteins
AU3766800A (en) 48 human secreted proteins
AU3767300A (en) 47 human secreted proteins
AU3628700A (en) 49 human secreted proteins
AU1438201A (en) 25 human secreted proteins
AU1472701A (en) 28 human secreted proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase